Telephone Disease Management At-Risk Drinking (TDM II)

Completed · Not applicable

Conditions studied: Alcohol Abuse

In brief

The aim of this study is to test for improvements in treatment outcomes for primary care patients with at-risk drinking when cared for using telephone disease management (TDM) compared to those treated with usual care. Based on our pilot data, TDM for at-risk drinking may be a viable method for reducing alcohol consumption in this population. Hypotheses: The hypotheses for this research plan are: 1. A significantly greater proportion of patients assigned to TDM will obtain improvement in drinking outcomes compared to usual care. 2. TDM will lead to greater access to behavioral health care and higher intensity of treatment relative to usual care. This effect will be moderated by logistics such as transportation problems, physical functioning, and employment status. 3. More patients assigned to TDM will receive guideline adherent care.

Key facts

Study ID

NCT00123409

Run by

US Department of Veterans Affairs

People needed

146

Starts

2004-01-01

Expected to finish

2009-02-01

Last updated by the study team

2015-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• be 18 years of age and over, male or female.
• meet criteria for at-risk drinking as defined by drinking more than 21 standard drinks per week (14 for women or those over age 65).

You may not qualify if…

• show an absence of any of the following:
• active suicidal ideation,
• regular current use of illicit substances other than alcohol
• diagnosis of current alcohol dependence
• current hallucinations and delusions
• current symptoms of PTSD
• a history of mania or hypomania.
• have adequate hearing to participate in telephone assessments and access to a telephone. Subjects will also show an absence of other barriers to verbal communication (e.g., aphasia) and will be cognitively intact (Brief Orientation Memory and Concentration task greater than 15 for those over age 54).
• not actively participating in specialized addiction treatment within the prior 3-months.
• not currently enrolled in another clinical trial
• not expected to move from the VISN 4 area within 12 months

Where it is running

• Philadelphia VA Medical Center, Philadelphia, PA — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.